Get App
Download App Scanner
Scan to Download
Advertisement

ICICI Lombard Q4 Results Review: Motilal Oswal Trims Target Price But Maintains Rating — Here's Why

ICICI Lombard's retail health segment continues its strong momentum, gaining market share through effective new customer acquisition, strong distribution capabilities, and significant traction of its "Elevate" product.

ICICI Lombard Q4 Results Review: Motilal Oswal Trims Target Price But Maintains Rating — Here's Why
ICICI Lombard witnessed a better-than-industry growth trajectory in H2 FY26, driven by recovery in motor insurance and strong market share gain in retail health.
(Photo: NDTV via agencies)
STOCKS IN THIS STORY
ICICI Lombard General Insurance Co Ltd
--

NDTV Profit's special research section collates quality and in-depth equity and economy research reports from across India's top brokerages, asset managers and research agencies. These reports offer NDTV Profit's subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Motilal Oswal Report

ICICI Lombard General Insurance Co. Ltd. witnessed a better-than-industry growth trajectory in H2 FY26, driven by recovery in motor insurance (owing to GST cuts) and strong market share gain in retail health (additional boost from GST exemption).

The company's retail health segment continues its strong momentum, gaining market share through effective new customer acquisition, strong distribution capabilities, and significant traction of its "Elevate" product.

Competitive intensity remains high in the motor OD segment, but the company has witnessed recovery driven by rising fresh vehicle sales. While the commercial lines segment is expected to face heightened competition, ICICI Lombard is well-positioned to capture profitable business within the segment.

Motilal Oswal cuts its NEP/PAT estimates by 2%/3% and 6%/2%, respectively, for FY26/27, considering ICICI Lombard's Q4 FY26 performance.

The brokerage expects the combined ratio to improve to 101.8% by FY28, given a stable claims environment and continued operational efficiency. Reiterate Buy with a target price of Rs 2,230 (based on 28 times FY28E earnings per share).

Click on the attachment to read the full report:

Motilal Oswal Icici Lombard Q4fy26 Results Review.pdf
VIEW DOCUMENT

ALSO READ: Wipro Dividend Announcement: Can The IT Giant Break Seven-Year Jinx?

DISCLAIMER

This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.

To continue reading this story
You must be an existing Premium User

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search
Add NDTV Profit As Google Preferred Source
Loading PDF...